The US Food and Drug Administration's Sentinel Initiative: Expanding the horizons of medical product safety

Authors


M. A. Robb, Office of Medical Policy, Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave, Building 51, Room 6360, Silver Spring, MD 20993, USA. E-mail: Melissa.Robb@fda.hhs.gov

No abstract is available for this article.

Ancillary